Ecto-GPR37: a potential biomarker for Parkinson ’s disease
ConclusionGPR37 expression is increased in SN of sporadic PD patients. The ecto-GPR37 peptides are significantly increased in the CSF of PD patients, but not in AD patients. These results open perspectives and encourage further clinical studies to confirm the validity and utility of ecto-GPR37 as a potential PD biomarker.
Source: Translational Neurodegeneration - Category: Neurology Source Type: research
More News: Alzheimer's | Brain | Nanotechnology | Neurology | Parkinson's Disease | Study | Toxicology